| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |